Clinical trials
Akeso’s Biliary Tract Win Shows ivonescimab Beyond Lung Cancer
Akeso’s CEO highlights a phase-3 success in biliary tract cancer while defending the drug’s data amid NSCLC concerns.
Fierce Biotech
A source referenced in Bench to Bed coverage of Medical Research. Stories crediting this source are aggregated and rewritten by the Bench to Bed editorial team, linked to the original report where available.